Polyrizon commences GMP manufacturing process for PL-14 allergy blocker
Polyrizon (PLRZ) has commenced preliminary work related to the Good Manufacturing Practice – GMP – manufacturing process for its PL-14 allergy ...
The State19d
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
"Once operational, our GMP facility stands ready to support the development of next-generation genetic medicines with a cell-free, enzymatic approach to IVT template production that confers the ...
Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization effortsRaanana, Israel, Jan. 23, ...